Cargando…

Cost-Effectiveness of Rate- and Rhythm-Control Drugs for Treating Atrial Fibrillation in Korea

PURPOSE: Although the economic and mortality burden of atrial fibrillation (AF) is substantial, it remains unclear which treatment strategies for rate and rhythm control are most cost-effective. Consequently, economic factors can play an adjunctive role in guiding treatment selection. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min, Kim, Woojin, Kim, Changsoo, Joung, Boyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881713/ https://www.ncbi.nlm.nih.gov/pubmed/31769246 http://dx.doi.org/10.3349/ymj.2019.60.12.1157

Ejemplares similares

Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data
por: Kim, Woojin, et al.
Publicado: (2023)

Optimal Rhythm Control Strategy in Patients With Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2022)

Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
por: Kim, Hyunmee, et al.
Publicado: (2018)

Comparison of Rhythm and Rate Control Strategies for Stroke Occurrence in a Prospective Cohort of Atrial Fibrillation Patients
por: Choi, Yu Jeong, et al.
Publicado: (2018)

Sex Difference in Effectiveness of Early Rhythm- over Rate-Control in Patients with Atrial Fibrillation
por: Kang, Dong-Seon, et al.
Publicado: (2022)

Comparative occurrence of ischemic stroke with the rhythm versus rate control strategy in a national prospective cohort of atrial fibrillation
por: Kim, Jae Guk, et al.
Publicado: (2021)

Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2021)

Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality‐of‐Life Score: The CODE‐AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry
por: Kim, Ju Youn, et al.
Publicado: (2022)

Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study
por: Kim, Daehoon, et al.
Publicado: (2021)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022)

Rhythm Control and Cardiovascular or Cerebrovascular Outcomes in Patients with Atrial Fibrillation: A Study of the CODE-AF Registry
por: Chung, Ho-Gi, et al.
Publicado: (2023)

Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation
por: Blackhouse, Gord, et al.
Publicado: (2013)

Prevention of Dementia in Patients with Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2021)

Challenging Achievement of Bidirectional Block After Linear Ablation Affects the Rhythm Outcome in Patients With Persistent Atrial Fibrillation
por: Kim, Tae‐Hoon, et al.
Publicado: (2016)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
por: Kim, Hyeongsoo, et al.
Publicado: (2020)

Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: A nationwide cohort study
por: Yu, Ga-In, et al.
Publicado: (2023)

A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry
por: Kim, Hyeongsoo, et al.
Publicado: (2017)

The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data
por: Lee, Hancheol, et al.
Publicado: (2017)

Association of obesity with incident atrial fibrillation in Korea and the United Kingdom
por: Choi, Sung Hwa, et al.
Publicado: (2023)

Risk Factor Management for Atrial Fibrillation
por: Joung, Boyoung
Publicado: (2019)

The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society
por: Jung, Byung Chun, et al.
Publicado: (2015)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease
por: Kim, D, et al.
Publicado: (2023)

Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry)
por: Song, Shinjeong, et al.
Publicado: (2022)

Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation
por: Cho, Min Soo, et al.
Publicado: (2021)

Lower pulmonary vein-to-left atrium volume ratio predicts poor rhythm outcome after atrial fibrillation catheter ablation
por: Lee, Jae-Hyuk, et al.
Publicado: (2022)

The Effects of a Bidirectional Cavo-Tricuspid Isthmus Block in Persistent Atrial Fibrillation
por: Kim, Jin-Bae, et al.
Publicado: (2012)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation?
por: Yang, Pil-Sung, et al.
Publicado: (2017)

Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
por: Koniari, Ioanna, et al.
Publicado: (2022)

Recent advances in rhythm control for atrial fibrillation
por: Bond, Richard, et al.
Publicado: (2017)

Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
por: Lim, Hoong Sern, et al.
Publicado: (2004)

Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
por: Yang, Pil-Sung, et al.
Publicado: (2018)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
por: Hwang, Inseok, et al.
Publicado: (2022)

Early rhythm control for atrial fibrillation: looking cost-effective, at least from one direction
por: Morin, Daniel P
Publicado: (2023)

Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)
por: Park, Junbeom, et al.
Publicado: (2022)

Regional and Socioeconomic Inequality of Atrial Fibrillation with Regular Hospital Visit
por: Yang, Pil-Sung, et al.
Publicado: (2018)

Early rhythm control vs. rate control in atrial fibrillation: A systematic review and meta-analysis
por: Han, Shaojie, et al.
Publicado: (2023)

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023)

Data for rate versus rhythm control strategy on stroke and mortality in patients with atrial fibrillation
por: Weng, Chi-Jen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v5m3rfe3pm7ehkegq9icqpjt64